WuXi Biologics (Cayman) Inc. has filed a Next Day Disclosure Return with the Hong Kong Stock Exchange, announcing the issuance of new shares. On May 15, 2025, the company issued a total of 158,500 new shares. These shares were issued under the Pre-IPO Share Option Scheme at prices of HKD 1.97 and HKD 1.29 per share for non-directors and directors, respectively.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.